Search results for "Retinal"

showing 10 items of 631 documents

Systemische fibrinolytische Therapie mit Urokinase bei Zentralarterienverschluss der Netzhaut

2005

BACKGROUND AND OBJECTIVE Systemic fibrinolysis has become an important therapeutical option in patients with thrombotic occlusion of coronary or pulmonary arteries. In view of the hemorrhagic risk systemic fibrinolytic therapy for retinal vessel occlusion has been discussed controversial. In the present case study results and complications of systemic fibrinolysis should be investigated in patients with central retinal artery occlusion. PATIENTS AND METHODS From 1995 to 2002 a case series of 19 consecutive patients (8 female, 11 male, age: 63.2+/-14,3 years) with central retinal artery occlusion were treated by systemic application of urokinase using a standardized scheme. The latency from …

Urokinasemedicine.medical_specialtyVisual acuitybusiness.industrymedicine.medical_treatmentGeneral MedicineThrombophiliamedicine.diseaseSurgeryFibrinolysisOcclusionmedicineCentral retinal artery occlusionMedical historyHemorrhagic riskmedicine.symptombusinessmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis

2011

Fibronectin (FN) is a major component of the extracellular matrix and functions in cell adhesion, cell spreading and cell migration. In the retina, FN is transiently expressed and assembled on astrocytes (ACs), which guide sprouting tip cells and deposit a provisional matrix for sprouting angiogenesis. The precise function of FN in retinal angiogenesis is largely unknown. Using genetic tools, we show that astrocytes are the major source of cellular FN during angiogenesis in the mouse retina. Deletion of astrocytic FN reduces radial endothelial migration during vascular plexus formation in a gene dose-dependent manner. This effect correlates with reduced VEGF receptor 2 and PI3K/AKT signalli…

Vascular Endothelial Growth Factor AIntegrinsAngiogenesisIntegrinNeovascularization PhysiologicMice TransgenicExtracellular matrixMicePhosphatidylinositol 3-KinasesCell MovementAnimalsProtein Interaction Domains and MotifsMolecular BiologyResearch ArticlesMice KnockoutSprouting angiogenesisbiologyRetinal VesselsCell migrationKinase insert domain receptorVascular Endothelial Growth Factor Receptor-2Extracellular MatrixFibronectinsCell biologyMice Inbred C57BLFibronectinVascular endothelial growth factor AAstrocytesbiology.proteinHeparitin SulfateOligopeptidesProto-Oncogene Proteins c-aktIntegrin alpha5beta1Signal TransductionDevelopmental BiologyDevelopment
researchProduct

Risk of Death Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-analysis.

2020

Importance Although intravitreal anti–vascular endothelial growth factor (VEGF) treatment represents the first-line therapy for many retinal diseases, the issue of their systemic safety is debatable. Objectives To assess whether intravitreal anti-VEGF therapy might be associated with increased risk of mortality and which variables are associated with the increase. Data Sources PubMed, MEDLINE, and Embase databases, the Cochrane Library, and ClinicalTrials.gov were systematically searched from inception to May 6, 2019. Study Selection Randomized clinical trials comparing intravitreal anti-VEGF treatment with control groups and with follow-up of at least 6 months were selected. Data Extractio…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyDatabases FactualMEDLINEAngiogenesis InhibitorsCochrane LibraryMacular Edemalaw.inventionRandomized controlled triallawFrequentist inferenceInternal medicineCause of DeathRetinal Vein OcclusionMedicineHumansanti-VEGF therapyrisk of mortality anti-vascular endothelial growth factor mortalityCause of deathOriginal InvestigationRandomized Controlled Trials as TopicDiabetic Retinopathybusiness.industryMortality rateOdds ratioChoroidal NeovascularizationOphthalmologyMeta-analysisIntravitreal InjectionsWet Macular DegenerationbusinessJAMA ophthalmology
researchProduct

Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis

2020

Purpose: To compare efficacy of treat and extend (T&E) versus fixed regimen treatment protocols in neovascular age-related macular degeneration (nAMD). Methods: Randomized clinical trials (RCTs) comparing T&E versus fixed regimen protocols for nAMD were systematically searched. Primary outcome was to compare the mean best corrected visual acuity (BCVA) change in T&E regimen versus fixed regimen. Secondary outcomes were change in the mean optical coherence tomography (OCT) central retinal thickness (CRT) and mean number of injections. Standardized mean difference (SMD) along with 95% confidence intervals (CIs) were calculated. Random-effect models were used for meta-analyses. Res…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyretinaretinal pathology/researchVisual AcuityAngiogenesis InhibitorsTreat and extendlaw.inventionMacular DegenerationRandomized controlled trialClinical Protocolsretina – medical therapieslawInternal medicineAge relatedRanibizumabMedicineHumansbusiness.industryAge-related macular degenerationGeneral MedicineMacular degenerationpediatric ophthalmologyretina – medical therapiemedicine.diseaseOphthalmologyRegimenTreatment OutcomeMeta-analysisvitreous/retinal diseaseIntravitreal InjectionsWet Macular DegenerationPediatric ophthalmologypharmacologybusinessTomography Optical CoherenceAge-related macular degeneration; pediatric ophthalmology; pharmacology; retina; retina – medical therapies; retinal pathology/research; vitreous/retinal disease
researchProduct

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections

2022

Background and Objectives: Brolucizumab is a novel anti-vascular endothelial growth factor (VEGF), whose efficacy has been shown in the Hawk and Harrier phase 3 clinical studies. The goal of the present case series is to report initial results of brolucizumab intravitreal injections (IVI) on type 3 neovascularization in neovascular age-related macular degeneration (nAMD), evaluated by optical coherence tomography angiography (OCTA). Materials and Methods: This is a bicentric retrospective case series. Patients with newly diagnosed type 3 MNV treated with brolucizumab IVI and at least 6 months follow-up were enrolled. OCTA en face images and B-scans were analyzed for lesions at baseline, 1 m…

Vascular Endothelial Growth Factor Atype 3 neovascularization.brolucizumabNeovascularization PathologicVisual Acuityneovascular age-related macular degeneration; type 3 neovascularization; retinal angiomatous proliferation; brolucizumab; optical coherence tomography angiography; intravitreal injectionintravitreal injectionretinal angiomatous proliferationEndothelial Growth Factorsneovascular age-related macular degenerationGeneral MedicineAntibodies Monoclonal Humanizedoptical coherence tomography angiographyIntravitreal InjectionsHumansFluorescein AngiographyTomography Optical CoherenceRetrospective StudiesMedicina
researchProduct

Changes in visual function and retinal structure in the progression of Alzheimer's disease

2019

Background Alzheimer's Disease (AD) can cause degeneration in the retina and optic nerve either directly, as a result of amyloid beta deposits, or secondarily, as a result of the degradation of the visual cortex. These effects raise the possibility that tracking ophthalmologic changes in the retina can be used to assess neurodegeneration in AD. This study aimed to detect retinal changes and associated functional changes in three groups of patients consisting of AD patients with mild disease, AD patients with moderate disease and healthy controls by using non-invasive psychophysical ophthalmological tests and optical coherence tomography (OCT). Methods We included 39 patients with mild AD, 2…

Visual acuitygenetic structuresVisionVisual AcuitySocial SciencesAlzheimer's DiseaseDiagnostic Radiologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesContrast (vision)PsychologyTécnicas de la imagenTomographymedia_commonCognitive ImpairmentMultidisciplinaryCognitive NeurologyRadiology and ImagingQRNeurodegenerative Diseasesmedicine.anatomical_structureNeurologyOptic nerveDisease ProgressionMedicineOftalmologíaSensory Perceptionmedicine.symptomAnatomyColor PerceptionTomography Optical CoherenceResearch Articlemedicine.medical_specialtyImaging TechniquesSciencemedia_common.quotation_subjectOcular AnatomyCognitive NeuroscienceResearch and Analysis MethodsRetinaContrast Sensitivity03 medical and health sciencesAlzheimer DiseaseOcular SystemDiagnostic MedicineOphthalmologyMental Health and PsychiatrymedicinePsychophysicsHumansOuter nuclear layerGanglion cell layerVision OcularRetinaColor Visionbusiness.industryBiology and Life SciencesRetinaleye diseasesGeriatríachemistry030221 ophthalmology & optometryEyesCognitive ScienceDementiaChoroidsense organsbusinessHead030217 neurology & neurosurgeryNeuroscience
researchProduct

Effect of Light Scattering Simulation in the Eye on Different Color Stimuli Perception

2008

One of the factors which influences visual functions is intraocular light scattering. To assess the effect of light scattering and stimulus color on visual functions, visual acuity and retinal straylight were measured with and without light scattering occluder. For visual acuity measurements black Landolt optotypes on red, green and blue background were used. Retinal straylight was measured with a direct compensation method using the same colors stimuli. For one subject straylight was measured with 5 different light scattering levels of eye occluder.

Visual acuitygenetic structuresmedia_common.quotation_subjectRetinalStimulus (physiology)eye diseasesLight scatteringchemistry.chemical_compoundchemistryPerceptionmedicineOptometrymedicine.symptomPsychologymedia_common
researchProduct

[37] Interactions between vitamin A and vitamin E in liposomes and in biological contexts

1999

Publisher Summary This chapter discusses the interactions between vitamin A and vitamin E in liposomes. The chapter reviews several studies carried out by incorporating a variable proportion of all- trans -retinol and α-tocopherol in soybean phosphatidylcholine liposomes. It discusses the antioxidant effectiveness of all- trans - retinol in retinal membranes, whether deprived of endogenous α-tocopherol. In the experiments discussed in the chapter, synergistic effects between all- trans -retinal and α -tocopherol are evident in chemical bilayer as well as in natural membranes. In addition, when all- trans -retinol and α –tocopherol are allowed to act in combination, consumption of both antio…

VitaminAntioxidantAutoxidationmedicine.medical_treatmentVitamin ERetinolfood and beveragesRetinalLipid peroxidationchemistry.chemical_compoundchemistryBiochemistrymedicinelipids (amino acids peptides and proteins)Tocopherol
researchProduct

Comparative assessment of the toxicology of vitamin A and retinoids in man.

1989

As the title implies, any assessment of the toxic effects of vitamin A derivatives must distinguish between vitamin A in the truest sense, i.e. retinol, and retinoic acid and its synthetic derivatives. Just as no single description is universally applicable to the mode of action of vitamin A derivatives, so too do their toxic effects defy generalization. The recommendation made in 1982 by IUPAC [Eur. J. Biochem., 129 (1989) 1] to designate all derivatives with the typical structure of the vitamin as being retinoids may be chemically logical and correct but, when it comes to describing the effects and side-effects of vitamin A derivatives, it leads to misunderstandings. Retinol, which is fre…

Vitaminmedicine.medical_specialtyRetinolRetinoic acidRetinalBiologyToxicologyHypervitaminosismedicine.diseaseVitamin A deficiencychemistry.chemical_compoundRetinoidsStructure-Activity RelationshipEndocrinologyBiochemistrychemistryInternal medicinemedicineAnimalsHumansMode of actionVitamin AOrganismToxicology
researchProduct

Classification of diabetes-related retinal diseases using a deep learning approach in optical coherence tomography

2019

Background and objectives: Spectral Domain Optical Coherence Tomography (SD-OCT) is a volumetric imaging technique that allows measuring patterns between layers such as small amounts of fluid. Since 2012, automatic medical image analysis performance has steadily increased through the use of deep learning models that automatically learn relevant features for specific tasks, instead of designing visual features manually. Nevertheless, providing insights and interpretation of the predictions made by the model is still a challenge. This paper describes a deep learning model able to detect medically interpretable information in relevant images from a volume to classify diabetes-related retinal d…

Volumetric imagingComputer scienceProfundo InterpretabilidadConvolutional neural network030218 nuclear medicine & medical imagingPattern Recognition Automatedchemistry.chemical_compoundMacular Degeneration[SPI]Engineering Sciences [physics]0302 clinical medicineDeep learning modelsInterpretabilityModelos de aprendizajeAged 80 and overArtificial neural networkmedicine.diagnostic_testMedical findings KeyWords Plus:MACULAR DEGENERATIONAngiographyMiddle AgedRetinal diseases3. Good healthComputer Science ApplicationsArea Under CurveTomographyMedical findingsAlgorithmsTomography Optical CoherenceAprendizaje - ModelosDiabetic macular edemaHealth InformaticsHallazgos médicosMacular Edema03 medical and health sciencesDeep LearningOptical coherence tomographymedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingDeep InterpretabilityHumans[INFO]Computer Science [cs]Enfermedades de la retinaRetinopathyAgedDiabetic RetinopathyOptical coherence tomographybusiness.industryDeep learningReproducibility of ResultsRetinalPattern recognitionMacular degenerationmedicine.diseasechemistryArtificial intelligenceNeural Networks ComputerLa tomografía de coherencia ópticabusinessClassifier (UML)030217 neurology & neurosurgerySoftware
researchProduct